Bridging From Discovery to Impact

Bridging From Discovery to Impact

Bridging From Discovery to Impact

Where surgical precision meets venture ambition.

Contact

Contact

Investment verticals

We invest in innovative companies focused on:

We invest in innovative companies focused on:

We invest in innovative companies focused on:

Cancer Treatment

Seeking first-in-class innovations that redefine the standard of care, targeting mechanisms and modalities that have never before been brought to the clinic.

Cancer Treatment

Seeking first-in-class innovations that redefine the standard of care, targeting mechanisms and modalities that have never before been brought to the clinic.

Cancer Treatment

We pursue first-in-class oncology innovations that target previously undruggable biology, seeking white-space opportunities in unexplored cancer mechanisms to redefine what treatment can look like.

Autoimmune Diseases

Backing novel therapeutics that silence autoimmune disease at its source and deliver durable outcomes where existing treatments have fallen short.

Autoimmune Diseases

Backing novel therapeutics that silence autoimmune disease at its source and deliver durable outcomes where existing treatments have fallen short.

Autoimmune Diseases

Backing novel therapeutics that silence autoimmune disease at its source and deliver durable outcomes where existing treatments have fallen short.

Accelerative AI

Investing in AI-native platforms that can transform clinical and drug design workflows and accelerate the path to the patient..

Accelerative AI

Investing in AI-native platforms that can transform clinical and drug design workflows and accelerate the path to the patient..

Accelerative AI

Investing in AI-native platforms that can transform clinical and drug design workflows and accelerate the path to the patient..

Unmet Patient Need

Supporting companies with platforms, assets, or algorithms with the potential to redefine standard of care, and expand healthspan.

Unmet Patient Need

Supporting companies with platforms, assets, or algorithms with the potential to redefine standard of care, and expand healthspan.

Unmet Patient Need

Supporting companies with platforms, assets, or algorithms with the potential to redefine standard of care, and expand healthspan.

Our Companies

Portfolio

Portfolio

View All

View All


The next generation of life-saving companies is being built now. Contact us to take your place. 

We commit
as one team.

Meet Us

Meet Us

Firm Highlights

The Numbers

The Numbers

We’re a domain-expert powered VC with extensive biotech founding experience.

Our Values

What We Value

01

Innovation

We champion bold, unconventional thinking — backing the scientists and entrepreneurs who are willing to challenge dogma and pursue the discoveries that others overlook.

02

Rigor

We look for companies built on a foundation of rigorous science — where every hypothesis is stress-tested, every data point is defensible, and the path to the clinic is grounded in evidence rather than assumption.

03

Velocity

We seek companies that treat time as a competitive advantage — driving from discovery to the clinic with the urgency that patients deserve.

04

Patient Impact

We invest in companies targeting genuine clinical needs and where the science addresses a problem the world cannot afford to leave unsolved.

©2025. All rightS reserved